Cytophage Technologies (TSXV:CYTO.H) Net Margin %: 0.00% (As of Dec. 2025)


What is Cytophage Technologies Net Margin %?

Cytophage Technologies TSXV:CYTO.H Net Margin % is 0.00% as of Dec. 2025. The stock has 1 warning sign investors should review. Among 947 Biotechnology companies, Cytophage Technologies ranks worse than 105596.52% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Cytophage Technologies's Net Income for the three months ended in Dec. 2025 was C$-0.81 Mil. Cytophage Technologies's Revenue for the three months ended in Dec. 2025 was C$0.00 Mil. Therefore, Cytophage Technologies's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Cytophage Technologies's Net Margin % or its related term are showing as below:


TSXV:CYTO.H's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.56
* Ranked among companies with meaningful Net Margin % only.

Cytophage Technologies  (TSXV:CYTO.H) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Cytophage Technologies Net Margin % Related Terms

Cytophage Technologies Net Margin % Historical Data

* Premium members only.

The historical data trend for Cytophage Technologies's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Net Margin % Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
0.00 0.00 0.00 0.00 0.00

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSXV:CYTO.H vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Cytophage Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cytophage Technologies Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytophage Technologies's Net Margin % distribution charts can be found below:

* The bar in red indicates where Cytophage Technologies's Net Margin % falls into.


Cytophage Technologies Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Cytophage Technologies's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-4.131/0
= %

Cytophage Technologies's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.806/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Cytophage Technologies (TSXV:CYTO.H) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Cytophage Technologies and its competitors. According to the industry distribution chart, Cytophage Technologies ranks #999999 out of 947 companies in the Biotechnology industry.
Is Cytophage Technologies' Net Margin % too high?
Cytophage Technologies' current Net Margin % is 0.00%. Based on the distribution chart, Cytophage Technologies ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Cytophage Technologies' Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Cytophage Technologies ranks #999999 out of 947 companies for Net Margin %. This places Cytophage Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Cytophage Technologies and its competitors. Cytophage Technologies's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytophage Technologies stock overvalued right now?
Cytophage Technologies (TSXV:CYTO.H) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Cytophage Technologies (TSXV:CYTO.H), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cytophage Technologies Business Description

Address 400 Fort Whyte Way, Suite 200A, Oak Bluff, MB, CAN, R4G 0B1
Cytophage Technologies Ltd is a Canadian biotechnology company engaged in the development of bacteriophages using molecular genetics and synthetic biology techniques. The company focuses on developing bacteriophage-based solutions to address bacterial challenges affecting animal health, human health, and food security, including antibiotic-resistant bacterial strains.